Lake Street Private Wealth’s Cymabay Therapeutics CBAY Stock Holding History

Lake Street Private Wealth’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,900	Closed	-$112K	–	303
2023 Q1	$112K	Hold	12,900	–	–	0.02%	272
2022 Q4	$80.9K	Hold	12,900	–	–	0.02%	270
2022 Q3	$45K	Hold	12,900	–	–	0.01%	270
2022 Q2	$38K	Hold	12,900	–	–	0.01%	287
2022 Q1	$40K	Hold	12,900	–	–	0.01%	305
2021 Q4	$44K	Hold	12,900	–	–	0.01%	323
2021 Q3	$47K	Buy	+12,900	New	+$50.8K	0.01%	231

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Lake Street Private Wealth's CBAY Position: Q2 2023 in Review

Lake Street Private Wealth sold out of Cymabay Therapeutics (CBAY) in Q2 2023, closing a stake of 12,900 shares — an estimated $112K sold.

Lake Street Private Wealth first reported a position in CBAY in Q3 2021 and held it in 7 quarters. The position peaked at $112K in Q1 2023. 151 funds tracked by Wall St. Rank hold CBAY as of Q2 2023.

Lake Street Private Wealth reported no remaining Cymabay Therapeutics position as of Q2 2023 after selling out during the quarter.
Lake Street Private Wealth sold 12,900 Cymabay Therapeutics shares in Q2 2023, an estimated $112K.
Lake Street Private Wealth first reported a position in Cymabay Therapeutics in Q3 2021 and held it in 7 quarters.
Lake Street Private Wealth's Cymabay Therapeutics position peaked at $112K in Q1 2023.
151 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2023.

Based on Lake Street Private Wealth's 13F filing for Q2 2023, filed 18 Jul 2023.